Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 29, 2015 8:20 PM ET

Biotechnology

Company Overview of Agouron Pharmaceuticals, Inc.

Key Executives for Agouron Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Glenn R. Zinser No RelationshipsCorporate Vice President of Operations71
Marvin R. Brown M.D. 3 RelationshipsVice President and president of Alanex67
Gary E. Friedman 7 RelationshipsVice President, Secretary, Counsel and Director67
Donna M. C. Nichols No RelationshipsVice President of Corporate Communications58
R. Kent Snyder No RelationshipsSenior Vice President - Commercial affairs60

Agouron Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Gary E. Friedman 7 RelationshipsAgouron Pharmaceuticals, Inc.67
John N. Abelson Ph.D. 3 RelationshipsAnnai Systems Inc.75
Patricia M. Cloherty 123 RelationshipsLexicon Pharmaceuticals, Inc.71
Irving S. Johnson Ph.D. 3 RelationshipsLigand Pharmaceuticals Incorporated88
View All Board Members

Agouron Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
316.0K
Bonus
204.6K
Total Short Term Compensation
384.8K
Total Value of Options
21.3M
Compensation as of Fiscal Year
Agouron Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

EMS Find, Inc. Announces Board Changes
March 26, 2015 9:25 PM ET
WD-40 Company Appoints Melissa Claassen to Board of Directors; Declares Regular Quarterly Dividend, Payable on April 30, 2015
March 24, 2015 3:47 PM ET
ZIL Limited Announces Board Changes
March 17, 2015 10:42 AM ET
Colgate-Palmolive Announces Board Changes
March 13, 2015 1:00 PM ET
Eveready Industries India Limited Announces the Demise of Deepak Khaitan, Vice-Chairman and Non- Executive Director
March 09, 2015 12:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Agouron Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.